Epidemiology and prevalence of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae in humans, animals and the environment in West and Central Africa.
Africa, Central
/ epidemiology
Africa, Western
/ epidemiology
Animals
Anti-Bacterial Agents
/ pharmacology
Bacterial Proteins
/ genetics
Cattle
Chickens
Dogs
Drug Resistance, Bacterial
Enterobacteriaceae
/ drug effects
Enterobacteriaceae Infections
/ epidemiology
Environmental Microbiology
Humans
Plasmids
Prevalence
Rats
Swine
beta-Lactamases
Carbapenemase
Central and West Africa
Data
ESBL
Enterobacteriaceae
Systematic review
Journal
International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
02
04
2020
revised:
29
09
2020
accepted:
11
10
2020
pubmed:
20
10
2020
medline:
7
8
2021
entrez:
19
10
2020
Statut:
ppublish
Résumé
Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and carbapenemase-producing Enterobacteriaceae (CPE) are widespread. Here we used the 'One Health' approach to determine knowledge gaps on ESBL-E and CPE in West and Central Africa. We searched all articles on ESBL-E and CPE in these African regions published in PubMed, African Journals Online and Google Scholar from 2000 onwards. Among the 1201 articles retrieved, we selected 165 studies (West Africa, 118; Central Africa, 47) with data from 22 of the 26 West and Central Africa countries. Regarding the settings, 136 articles focused only on humans (carriage and/or infection), 6 articles on humans and animals, 13 on animals, 1 on humans and the environment, 8 on the environment and 1 on humans, animals and environments. ESBL-E prevalence ranged from 11-72% in humans and 7-79% in aquatic environments (wastewater). In animals, ESBL-E prevalence hugely varied: 0% in cattle, 11-36% in chickens, 20% in rats, 21-71% in pigs and 32-75% in dogs. The bla
Identifiants
pubmed: 33075511
pii: S0924-8579(20)30409-X
doi: 10.1016/j.ijantimicag.2020.106203
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
beta-Lactamases
EC 3.5.2.6
carbapenemase
EC 3.5.2.6
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
106203Informations de copyright
Copyright © 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.